v3.26.1
Consolidated Statements of Cash Flows - USD ($)
 3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2026
Mar. 31, 2026
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Cash Flows Used in Operating Activities              
Net loss $ (34,914,000) $ (27,783,000) $ (141,275,000) $ (253,674,000) $ (62,697,000) $ (394,949,000)  
Adjustments to reconcile net loss to net cash and cash equivalents used in operating activities:              
Stock-based compensation         10,309,000 15,247,000  
Interest income on debt securities - related party         (180,000) (195,000)  
Change in fair value of financial liabilities 2,188,000   (7,176,000)   2,125,000 (23,605,000)  
Non-cash interest expense on notes payable         1,119,000 2,560,000  
Net gain on investments         (107,000) 0  
Accrued unpaid interest on note payable         238,000 0  
Equity method investment loss         3,006,000 8,680,000  
Realized gain on conversion of available for sale investments 0   0   0 (1,507,000)  
Deferred income taxes         (4,585,000) (3,897,000)  
Loss on disposal of PPE         223,000 0  
Depreciation and amortization         11,331,000 11,182,000  
Goodwill impairment 0   113,344,000   0 346,557,000  
Other costs         1,100,000 165,000  
Changes in operating assets and liabilities:              
Accounts receivable         (1,025,000) (618,000)  
Prepaid expenses and other current assets         (4,779,000) (3,312,000)  
Inventory         (1,385,000) (1,442,000)  
Accounts payable         (619,000) 315,000  
Accrued employee benefits         (6,365,000) 1,330,000  
Accrued expenses         (6,722,000) 42,000  
Stock-based compensation liability         (26,000) (686,000)  
Income taxes payable         (5,000) 292,000  
Other current liabilities         (286,000) (78,000)  
Payment of patent installment         (700,000) (525,000)  
Contract liabilities         (413,000) 690,000  
Net Cash Used In Operating Activities         (59,466,000) (36,754,000)  
Cash Flows Used In Investing Activities              
Investment in available-for-sale debt securities - equity method investee         0 (2,708,000)  
Acquisition of property, plant and equipment         (1,074,000) (932,000)  
Net Cash Used In Investing Activities         (1,074,000) (3,640,000)  
Cash Flows Provided By Financing Activities              
Proceeds from issuance of equity, net of issuance costs         50,229,000 3,675,000  
Proceeds from the issuance of equity to non-controlling interest, net of issuance costs         0 5,367,000  
Proceeds from issuance of debt securities, net of issuance costs         0 27,000,000  
Payment of debts         (8,595,000) (1,176,000)  
Distributions to stockholders and other         0 (76,000)  
Net Cash Provided By Financing Activities         41,634,000 41,240,000  
Net Increase (Decrease) in Cash, Cash Equivalents, and Restricted Cash         (18,906,000) 846,000  
Cash, Cash Equivalents and Restricted Cash, Beginning of period   $ 65,449,000   $ 11,119,000 65,449,000 11,119,000 $ 11,119,000
Cash, Cash Equivalents and Restricted Cash, End of period 46,543,000   11,965,000   46,543,000 11,965,000 $ 65,449,000
Supplemental Cash Flow Information              
Cash paid for interest         1,097,000 1,825,000  
Supplemental Disclosure of Noncash Financing Information              
Conversion of working capital loans to equity method investee into investments in debt securities - related party         0 4,375,000  
Extinguishment of debt with Series C Preferred Stock         0 14,000,000  
Contribution of Series C Preferred Stock to equity method investee         0 5,783,000  
Conversion of AFX available-for-sale term loan into equity method investments         0 8,757,000  
Issuance of common stock as repayment of convertible debt         1,090,000 2,533,000  
Issuance of vested RSUs         1,276,000 0  
Issuance of stock in exchange for services         11,000 4,095,000  
Conversion of preferred stock into common stock         0 36,910,000  
Transfer of Series C Preferred Stock from Mezzanine to Stockholders' equity         0 1,468,000  
Embedded derivative in association with Convertible Debentures         0 1,774,000  
Equity reallocation between non-controlling interest and additional paid-in capital         0 25,268,000  
Nonrelated party              
Adjustments to reconcile net loss to net cash and cash equivalents used in operating activities:              
Loss on extinguishment of debt 0   3,462,000   977,000 3,462,000  
Cash Flows Provided By Financing Activities              
Proceeds from the issuance of related party convertible promissory notes and term convertible notes         0 2,451,000  
Related party              
Adjustments to reconcile net loss to net cash and cash equivalents used in operating activities:              
Loss on extinguishment of debt $ 0   $ 0   0 3,538,000  
Cash Flows Provided By Financing Activities              
Proceeds from the issuance of related party convertible promissory notes and term convertible notes         $ 0 $ 3,999,000